Biodexa Pharmaceuticals's total assets for Q2 2025 were £14.82M, an increase of 0.30% from the previous quarter. BDRX total liabilities were £3.39M for the fiscal quarter, a -47.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.